Literature DB >> 16288064

Rifampin reduces the analgesic effect of transdermal fentanyl.

Hiroshi Takane, Aya Nosaka, Hannosuke Wakushima, Kazuyo Hosokawa, Ichiro Ieiri.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16288064     DOI: 10.1345/aph.1G370

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


× No keyword cloud information.
  6 in total

1.  [Interaction of opioid analgesics at the level of biotransformation].

Authors:  H Petri; D Grandt
Journal:  Schmerz       Date:  2016-12       Impact factor: 1.107

2.  Prolonged therapy with the anticonvulsant carbamazepine leads to increased plasma clearance of fentanyl.

Authors:  Ala Nozari; Oluwaseun Akeju; Hooman Mirzakhani; Emad Eskandar; Zhijun Ma; Md Amin Hossain; Qingping Wang; David J Greenblatt; J A Jeevendra Martyn
Journal:  J Pharm Pharmacol       Date:  2019-02-21       Impact factor: 3.765

Review 3.  Transdermal matrix fentanyl membrane patch (matrifen): in severe cancer-related chronic pain.

Authors:  Philip I Hair; Gillian M Keating; Kate McKeage
Journal:  Drugs       Date:  2008       Impact factor: 9.546

4.  Efficacy and safety of fentanyl buccal for cancer pain management by administration through a soluble film: an update.

Authors:  Marvin Omar Delgado-Guay
Journal:  Cancer Manag Res       Date:  2010-11-24       Impact factor: 3.989

Review 5.  Clinically significant drug-drug interactions involving opioid analgesics used for pain treatment in patients with cancer: a systematic review.

Authors:  Aleksandra Kotlinska-Lemieszek; Pål Klepstad; Dagny Faksvåg Haugen
Journal:  Drug Des Devel Ther       Date:  2015-09-16       Impact factor: 4.162

6.  Rifampin Reduces the Plasma Concentrations of Oral and Intravenous Hydromorphone in Healthy Volunteers.

Authors:  Terhi J Lohela; Satu Poikola; Mikko Neuvonen; Mikko Niemi; Janne T Backman; Klaus T Olkkola; Tuomas O Lilius
Journal:  Anesth Analg       Date:  2021-08-01       Impact factor: 6.627

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.